Autori: Tobias Joshua
| Naslov | HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome (Meeting Abstract) |
| Autori | Tobias Joshua Kundi Michael Garner-Spitzer E Zielinski Christoph Maglakelidze Marina Andric Zoran G  Petrovic Z Nagarkar R Chawla T Chong LO Nixon B Yavrom S Ede NJ Wiedermann Ursula
|
| Info | ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 2, str. S864-S864 |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
     |
| Naslov | HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2t-argeting peptide vaccine plus SOC chemotherapy in patients with HER2+advanced stomach cancer - correlation of the antibody responses and clinical outcome (Meeting Abstract) |
| Autori | Tobias Joshua Kundi Michael Garner-Spitzer E Zielinski Christoph Maglakelidze Marina Andric Zoran G Petrovic Zeljko M Nagarkar R Chawla T Chong LMO Nixon B Yavrom S Ede NJ Wiedermann Ursula
|
| Info | ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 1, str. S4-S4 |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
| Naslov | Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia (Article) |
| Autori | Stojanovic Marijana M Lukic Ivana Marinkovic Emilija Kovacevic Ana Miljkovic Radmila Tobias Joshua Schabussova Irma Zlatovic Mario V Barisani-Asenbauer Talin Wiedermann Ursula Inic-Kanada Aleksandra B
|
| Info | VACCINES, (2020), vol. 8 br. 4, str. - |
| Projekat | Institute for Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Austria; Austrian Research Promotion Agency (FFG) [822768]; Ministry of Education, Science and Technological Development of Republic of Serbia [451-03-68/2020-14/20017 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
